CHRS
Coherus BioSciences Inc
Price:  
1.04 
USD
Volume:  
15,428,360.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CHRS Fair Value

-222.26 %
Upside

As of 2024-10-04, the Fair Value of Coherus BioSciences Inc (CHRS) is -1.27 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.04 USD, the upside of Coherus BioSciences Inc is -222.26%.

Note: valuation result may not be accurate due to the company's negative EPS.

1.04 USD
Stock Price
-1.27 USD
Fair Price
FAIR VALUE CALCULATION

CHRS Fair Value

Peter Lynch's formula is:

CHRS Fair Value
= Earnings Growth Rate x TTM EPS
CHRS Fair Value
= 5.00 x -0.25
CHRS Fair Value
= -1.27

The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.

Historical Earnings
2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31 5Y Avg
Net income 89.80 132.20 -287.10 -291.80 -237.89 -118.96
YoY growth 142.90% 47.22% -317.17% -1.64% 18.47% -22.04%

CHRS Fair Value - Key Data

Market Cap (mil) 119.82
P/E
Forward P/E
EPS -0.25
Avg earnings growth rate -22.04%
TTM earnings -29.30